Globus Medical, Inc. operates primarily through two business segments: Musculoskeletal Solutions and Enabling Technologies. The Musculoskeletal Solutions segment offers implantable devices, biologics, and neuromonitoring services used in spinal, orthopedic trauma, and joint reconstruction procedures. The Enabling Technologies segment features the Excelsius ecosystem, which includes imaging, navigation, and robotic solutions designed to assist surgeons and improve procedural outcomes. While the United States is its primary market, generating the vast majority of its revenue, the company maintains a growing international footprint across more than 60 countries. Globus Medical has expanded its scale and product portfolio through strategic acquisitions, including its transformative mergers with NuVasive and Nevro, solidifying its competitive position in the global spine and orthopedic markets.
